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Deregulation of the Sonic hedgehog pathway has been implicated in an increasing number of human cancers.
In this pathway, the seven-transmembrane (7TM) signaling protein Smoothened regulates cellular prolifera-
tion and differentiation through activation of the transcription factor Gli. The activity of mammalian Smooth-
ened is controlled by three different hedgehog proteins, Indian, Desert, and Sonic hedgehog, through their
interaction with the Smoothened inhibitor Patched. However, the mechanisms of signal transduction from
Smoothened are poorly understood. We show that a kinase which regulates signaling by many “conventional”
7TM G-protein-coupled receptors, G protein-coupled receptor kinase 2 (GRK2), participates in Smoothened
signaling. Expression of GRK2, but not catalytically inactive GRK2, synergizes with active Smoothened to
mediate Gli-dependent transcription. Moreover, knockdown of endogenous GRK2 by short hairpin RNA
(shRNA) significantly reduces signaling in response to the Smoothened agonist SAG and also inhibits signal-
ing induced by an oncogenic Smoothened mutant, Smo M2. We find that GRK2 promotes the association
between active Smoothened and -arrestin 2. Indeed, Gli-dependent signaling, mediated by coexpression of
Smoothened and GRK2, is diminished by -arrestin 2 knockdown with shRNA. Together, these data suggest
that GRK2 plays a positive role in Smoothened signaling, at least in part, through the promotion of an
association between -arrestin 2 and Smoothened.
The Sonic hedgehog (Shh) signaling pathway plays an im-
portant role in the development and homeostasis of an organ-
ism. Indeed, this cascade has been implicated in an ever-grow-
ing number of human malignancies. While the importance of
this pathway has been recognized for some time, the details of
signal transmission have not yet been fully elucidated in mam-
malian systems. Most of what is known about the Shh signaling
cascade comes from studies of Drosophila, where the pathway
was originally identified (35). In Drosophila, signaling from the
7TM protein Smoothened (Smo) arises when the secreted
hedgehog ligand (hh) binds to a 12-transmembrane transporter-
like protein, Patched (Ptc). The binding of hh to Ptc relieves
Ptc-mediated inhibition of Smo. Intracellularly, activation of
Smo leads to the disruption of a large protein complex com-
posed of a kinesin-like protein, Costal-2 (Cos2), the serine/
threonine kinase Fused, the Suppressor of Fused protein, and
the transcription factor effector Cubitus interruptus (Ci). In
the absence of the hh signal, this protein complex is tethered to
microtubules in the cytoplasm, providing one mechanism for
excluding Ci from the nucleus. Ci is further inhibited by pro-
tein kinase A (PKA) phosphorylation, which leads to the pro-
teolytic processing of Ci from a full-length transcriptional ac-
tivator into a 75-kDa transcriptional repressor. Pathway activation
through hh binding to Ptc leads to inhibition of Ci proteolysis and
allows nuclear accumulation of active Ci (for reviews, see refer-
ences 8, 16, and 21).
While the functions of Smo and Ptc are conserved in mam-
mals, the transduction of the signal through intracellular sig-
naling pathways remains less clear. The function of the single
Ci transcription factor in Drosophila is, in mammalian systems,
ascribed to a family of zinc finger transcription activators and
repressors, Gli1 to Gli3, of which Gli3 is also proteolytically
processed in a manner similar to that of Ci (17). As in Dro-
sophila, the Suppressor of Fused protein antagonizes Gli1 ac-
tivity by sequestering it in the cytoplasm (33, 44). Recently, it
has been shown that, in Drosophila, Cos2 interacts directly with
Smo, providing a link between Smo activation at the mem-
brane and the inhibition of proteolysis and nuclear accumula-
tion of Ci (19, 31, 36). While Kif27/Kif7 seems to be the
mammalian ortholog of Cos2, its functional conservation in the
pathway remains to be fully elucidated (23).
The closest structural relative of Smo is the Wnt receptor
Frizzled, which, like Smo, is a 7TM protein. However, while
the Wnt proteins are ligands for Frizzled, Smo has no known
natural ligand. Several pieces of evidence link Frizzled signal-
ing to G proteins; however, evidence implicating G proteins in
Smo signaling is very limited (1, 11, 22, 30, 45). It is tempting,
however, to speculate that Smo signaling may share some sim-
ilarities with other 7TM receptors (7TMRs). Classically, upon
agonist binding, 7TMRs undergo a conformational change that
mediates signal transduction through the activation of hetero-
trimeric G proteins. At the same time, phosphorylation of the
receptor by G-protein-coupled receptor kinases (GRKs) leads
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to feedback mechanisms that desensitize the 7TMR by uncou-
pling it from its G protein and promote internalization of the
receptor. A critical component in the desensitization/internal-
ization pathway is the -arrestin family of proteins. -Arrestins
are multifunctional cytoplasmic scaffold proteins that mediate
desensitization and internalization by recruiting components
of the endocytic machinery such as AP-2 and clathrin to a
GRK-phosphorylated receptor. The recruitment of -arrestin
to an activated receptor at the membrane directs the receptor
to clathrin-coated pits that are then endocytosed and trafficked
elsewhere in the cell for degradation or for recycling of the
receptor back to the membrane (for a review, see reference 7).
More recently, it has been appreciated that the -arrestin
protein can also play an important role in signal transmission
through the recruitment and scaffolding of cellular signaling
factors such as the tyrosine kinase Src and members of the
mitogen-activated protein kinase cascades JNK and ERK (for
reviews, see references 26 and 27). Thus, -arrestins and
GRKs have the capacity to turn off some signaling pathways
and promote signaling through others.
The structural similarity of Smo to the 7TMR family sug-
gests the possibility that Smo signaling involves the actions of
GRK and -arrestin. Supporting this possibility is the finding
that, in Drosophila, Smo is hyperphosphorylated upon activa-
tion (12, 39, 43, 48, 49). Furthermore, in mammalian systems,
GRK2 has recently been identified as a major kinase in acti-
vation-dependent Smo phosphorylation in human embryonic
kidney (HEK) cells (6). Finally, -arrestin has also recently
been shown to be a critical component in Smo-mediated zebra
fish development (46). Thus, given this supportive evidence, we
undertook the present studies to examine if GRK2 and -ar-
restin 2 play a role in Smo-dependent signaling.
MATERIALS AND METHODS
Plasmids. The 16.3 mutant Gli and 16.2 wild-type Gli reporter plasmids and
the Myc-Smoothened, Smoothened M2, Ptc, and Shh N terminus expression
plasmids were obtained from M. Scott (40). The Flag–-arrestin, green fluores-
cent protein (GFP)–-arrestin, bovine GRK2, and bovine GRK2 K220R expres-
sion plasmids were generated as described previously (3). The Myc-Smoothened,
GRK2, and GRK2 K220R retroviruses used for making stable lines of C3H10T1/2
cells were constructed by introducing the coding sequences into the pLXRN
(Smo) and pLPCX (GRK2 and GRK2 K220R) Clontech vectors. The short
hairpin RNAs (shRNAs) were cloned into the pSilencer 3.0 hygro vector (Am-
bion) with the following sequences: control, 5 GAT CCG TTC TCC GAA CGT
GTC ACG TTT CAA GAG AAC GTG ACA CGT TCG GAG AAT TTT TTG
GAA A 3 and 5 AGC TTT TCC AAA AAA TTC TCC GAA CGT GTC ACG
TTC TCT TGA AAC GTG ACA CGT TCG GAG AAC G 3; GRK2 1, 5 GAT
CCA TAT GAG AAG CTG GAG ACA TTC AAG AGA TGT CTC CAG CTT
CTC ATA TTT TTT TGG AAA 3 and 5 AGC TTT TCC AAA AAA ATA
TGA GAA GCT GGA GAC ATC TCT TGA ATG TCT CCA GCT TCT CAT
ATG 3; GRK2 2, 5 GAT CCG AAT GTT GAG CTC AAC ATC TTC AAG
AGA GAT GTT GAG CTC AAC ATT CTT TTT TGG AAA 3 and 5 AGC
TTT TCC AAA AAA GAA TGT TGA GCT CAA CAT CTC TCT TGA AGA
TGT TGA GCT CAA CAT TCG 3; GRK2 3, 5 GAT CCG GAA TCA AGT
TAC TGG ACA TTC AAG AGA TGT CCA GTA ACT TGA TTC CTT TTT
TGG AAA 3 and 5 AGC TTT TCC AAA AAA GGA ATC AAG TTA CTG
GAC ATC TCT TGA ATG TCC AGT AAC TTG ATT CCG 3; Barr2 1, 5
GAT CCC AGT GAA GCT GGT GGT GTC TTT CAA GAG AAG ACA CCA
CCA GCT TCA CTT TTT TTG GAA A 3 and 5 AGC TTT TCC AAA AAA
AGT GAA GCT GGT GGT GTC TTC TCT TGA AAG ACA CCA CCA GCT
TCA CTG G 3; Barr2 2, 5 GAT CCG CAA GAT GAC CAG GTG TCT CTT
CAA GAG AGA GAC ACC TGG TCA TCT TGT TTT TTG GAA A 3 and
5 AGC TTT TCC AAA AAA CAA GAT GAC CAG GTG TCT CTC TCT
TGA AGA GAC ACC TGG TCA TCT TGC G 3.
Mutagenesis. shRNA-resistant bovine GRK2 (GRK2 2*) was made with the
QuikChange site-directed mutagenesis kit (Stratagene) and primers 5 GTG
GAA GAA TGT AGA ACT AAA TAT ACA CCT GAC CAT GAA C 3 and
5 GTT CAT GGT CAG GTG TAT ATT TAG TTC TAC ATT CTT CCA C 3.
Tissue culture. C3H10T1/2 cells were cultured in Eagle’s basal medium con-
taining 10% fetal bovine serum, 1% penicillin-streptomycin, 0.1% gentamicin,
1.5 g/liter sodium bicarbonate, and 2 mM L-glutamine. HEK 293 cells were
cultured in Eagle’s minimum essential medium (MEM) with 10% fetal bovine
serum, 0.1% gentamicin, and 1% penicillin-streptomycin. Shh-LIGHT cells were
cultured in Dulbecco’s modified Eagle’s medium with 10% newborn calf serum,
0.1% gentamicin, and 1% penicillin-streptomycin. Experiments with SAG (see
Fig. 3A and C) were performed in the presence of 2% serum. Experiments with
SAG (see Fig. 2) were performed in the presence of 10% serum.
Focus formation assays. C3H10T1/2 cells stably expressing Smo alone, GRK2
alone, GRK2 K220R alone, Smo together with GRK2, or Smo together with
GRK2 K220R were plated in 35-mm dishes at a density of 1.5  105/dish. Cells
were transfected with 2 g of a plasmid expressing Ras 61L with the TransIT-
LT1 transfection reagent (Mirus). One plate of each was also transfected with a
plasmid expressing -galactosidase (gal) to verify that the transfection efficien-
cies were equal. After 48 h, the cells were split and plated into 60-mm dishes. The
medium was changed every 3 days for 21 days. Foci were then stained with crystal
violet stain and counted. Counted foci were brightly stained areas of dense cell
growth greater than approximately 1.5 mm in diameter.
Luciferase assay. C3H10T1/2 cells were plated at a density of 1.5  105/well
in a six-well dish. After 16 h, the cells were transiently transfected with the
indicated expression plasmids, a Gli reporter plasmid (0.5 g), and a cyto-
megalovirus (CMV)-gal (0.25 g) internal transfection control plasmid by
using the TransIT-LT1 transfection reagent (Mirus). The total amount of DNA
transfected was kept constant with the empty pCDNA3 plasmid. Cells were
allowed to grow for 72 h posttransfection with no change in medium. After 72 h,
cells were harvested and lysed in 1 reporter buffer (Promega.) Luciferase
activity was measured with the Luciferase Assay system (Promega) and normal-
ized to gal internal controls. For assays with agonists and antagonists, cells were
plated at a density of 3  105/60-mm plate. Cells were transiently transfected as
described above, and the reagent and DNA were adjusted for cell number. After
24 h, cells were split into two six-well dishes and treated (i) with 5 mM cyclo-
pamine in dimethyl sulfoxide (DMSO) at a final concentration of 0.001% or with
the DMSO vehicle for 48 h or (ii) with 0.3 mM benzo[b]thiophene-2-carboxam-
ide, 3-chloro-N-[4-(methylamino)cyclohexyl]-N-{[3-(4-pyridinyl)phenyl]methyl}-
(9CI) (SAG) (5) in DMSO at a final concentration of 0.001% or with the DMSO
vehicle for 48 h. Cells were then assayed for luciferase and gal activities. For
experiments with hairpins, cells were plated at a density of 3  105/60-mm plate.
Cells were transiently transfected as described above with the reporter plasmid
(1 g), CMV-gal (0.5 g), and the indicated shRNA (2 g). After 24 h, the cells
were split into two six-well dishes and treated with SAG or the vehicle for 48 h.
Cells were then assayed for luciferase and gal activities. shRNA rescue exper-
iments were performed as described above but with the addition of either
pCDNA3 or shRNA-resistant GRK2 (2 g) to the transfection. Experiments
with Smo and GRK2 to activate Smo-mediated signaling were performed by
plating cells at 1.5  105/well in a six-well plate. Cells were transfected with the
reporter plasmid (0.5 g), CMV-gal (0.25 g), pCDNA3 or Smo and GRK2 (2
g pCDNA3 or 1 g Smo plus 1 g GRK2), and the indicated shRNA (1 g).
Cells were assayed for luciferase and gal activities at 72 h posttransfection.
gal assay. gal activity was measured by adding a third of the extract pre-
pared for the luciferase assays to 570 l of 0.1 mg/ml chlorophenol red--D-
galactopyranoside in lacZ buffer (60 mM Na2HPO4, 40 mM NaH2PO4, 10 mM
KCl, 1 mM MgSO4, 38 mM 2-mercaptoethanol, pH 7.0). After incubation at
37°C until a visible color change takes place in all samples (5 to 40 min), the
absorbance of each sample is measured at 570 nm.
Coimmunoprecipitation assays. HEK 293 cells were transiently transfected
with the indicated expression plasmids by the calcium phosphate method. After
15 h of transfection, the medium was replaced with fresh complete MEM or
MEM containing 5 M cyclopamine where indicated. Forty hours posttransfec-
tion, cells were harvested and lysed in 1 ml immunoprecipitation buffer contain-
ing 50 mM HEPES, 0.5% NP-40, 250 mM NaCl, 10% glycerol, 2 mM EDTA, 1
mM phenylmethylsulfonyl fluoride, and a 1 protease inhibitor cocktail tablet
(Complete Mini; Roche). An aliquot of the extract (2%) was used as the input,
while the remaining extract was incubated with Flag-antibody beads (Sigma) that
had been preblocked with bovine serum albumin for 1 h. Extracts and beads were
allowed to mix at 4°C for 3 h. Beads were then washed five times in immuno-
precipitation buffer. Sample buffer was then added directly to the washed beads
and run on sodium dodecyl sulfate-polyacrylamide gels. The gels were trans-
ferred to membranes, which were then blotted with the appropriate antibody.
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Western blotting. For Western blotting of a transfected protein, samples were
loaded with gal values to normalize for transfection efficiency. Otherwise,
samples were loaded with an equal amount of total protein as measured by a DC
protein assay read at 750 nm (Bio-Rad). To detect the extent of knockdown with
GRK2 or arr2 shRNA, six 60-mm plates of cells were transfected with the
indicated plasmids and an empty GFP vector (0.5 g). Five plates of cells were
collected and sorted for GFP expression by flow cytometry. One plate was
assayed for luciferase activity and used as a data point for the experiment. Sorted
cells were lysed, and equal total protein was run on a 10% polyacrylamide gel.
Western blotting was then performed with the appropriate antibody (Myc-tagged
rabbit antibody from Abcam, human Smo [A2668] antibody from MBL, Flag–
M2-peroxidase antibody from Sigma, GRK2 [C-15] antibody from Santa Cruz,
actin antibody from Chemicon, or A1CT -arrestin antibody [2]). All Western
blot assays were done with SuperSignal West Pico chemiluminescent substrate
(Pierce), except for Western blot assays of Myc-Smo overexpression in
C3H10T1/2 cells (see Fig. 1B), which were done with the SuperSignal West
femto maximum-sensitivity substrate (Pierce).
Confocal microscopy. Shh-LIGHT cells (42) were transfected with the indi-
cated expression plasmids. After 24 h, cells were replated onto a confocal dish
with a glass bottom. At 48 h posttransfection, cells were examined by confocal
microscopy. Twenty-five green cells (indicating transfection with -arrestin
2–GFP) per plate (three plates per experiment) were counted for translocation
of -arrestin 2 to the membrane.
RESULTS
Smo and GRK2 synergize to activate the Shh pathway. To
identify a potential role for -arrestin 2 and GRK2 in signaling
through a Smo-dependent pathway, we first assayed the effects
of these proteins on the activation of Gli. C3H10T1/2 cells are
well known to respond to Shh by inducing Gli-dependent genes
(24, 34); therefore, this cell line was used to examine Smo-
FIG. 1. Synergistic activation of Gli by GRK2 and active Smo. (A) C3H10T1/2 cells were transiently transfected with the indicated expression
plasmids, a Gli luciferase reporter, and a gal transfection control. Luciferase values were adjusted for transfection efficiency relative to that of
a sample containing the reporter alone. Fold activation refers to the increase in luciferase activity of each sample relative to that of the sample
containing the reporter alone. (B, top) Cells were transfected as for panel A with the addition of a GFP plasmid. Cells were sorted by flow
cytometry, and lysates from equal numbers of cells were immunoblotted with Myc and actin antibodies. (B, bottom) Cells were transfected as for
panel A. Extracts used for luciferase assays were normalized for transfection efficiency and immunoblotted with a GRK2 antibody. A representative
blot of three independent experiments is shown. (C) Cells were transfected and assayed as for panel A. (D) Extracts from the experiments whose
results are shown in panel C were adjusted for transfection efficiency and immunoblotted with a GRK2 antibody. (E) C3H10T1/2 cells stably
expressing the indicated proteins were transfected with the Gli reporter and a gal transfection control. Luciferase assays were performed as for
panel A. (F) Cells were transfected as for panel A. After 24 h, the cells were split in half and treated with either the vehicle or cyclopamine for
48 h. Cells were then assayed for luciferase activity as for panel A. The data shown are the results of three independent experiments.
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dependent signaling. Transfection of C3H10T1/2 cells with
Smo and a luciferase reporter under the control of eight Gli
binding sites results in induction of the reporter by greater than
fourfold, revealing that exogenous expression of Smo can over-
come endogenous Ptc inhibition to induce signaling (Fig. 1A).
Expression of -arrestin 2 or GRK2 alone is not sufficient to
activate pathway signaling, nor does -arrestin 2 further en-
hance the induction of the reporter by Smo in cells transfected
with Smo and -arrestin 2 together. However, interestingly,
expression of Smo together with GRK2 results in a large syn-
ergistic activation (15- to 20-fold) of the reporter (Fig. 1A).
The Western analysis in Fig. 1B confirms that the exogenous
Smo and GRK2 proteins are expressed equally.
The finding that GRK2 can synergize with Smo to activate a
Gli-dependent reporter is interesting in the light of recent data
that reveal that GRK2 can also phosphorylate Smo (6). It is
therefore possible that the observed synergy between GRK2
and Smo is dependent on the ability of GRK2 to phosphorylate
Smo or some other target. To address the necessity of the
kinase activity of GRK2 for its ability to cooperate with Smo,
we examined if a kinase-inactive version of GRK2, GRK2
K220R, could also synergize with Smo (25). Figure 1C and D
reveal that, at equal levels of expression, only wild-type GRK2
is capable of synergizing with Smo to activate the reporter.
This suggests that the kinase domain of GRK2 is necessary for
GRK2 to synergize with Smo. Similar Gli reporter assays were
also performed with C3H10T1/2 cells stably expressing Smo,
GRK2, GRK2 K220R, Smo and GRK2, or Smo and GRK2
K220R, with similar results (Fig. 1E).
To further examine the nature of the observed Smo-GRK2
synergy, we next assessed if activation of Smo is necessary by
testing the effect of the Smo antagonist cyclopamine. Figure 1F
shows that while GRK2 could synergize with Smo to activate
Gli-dependent transcription in vehicle (DMSO)-treated cells,
inhibition of Smo through cyclopamine abolished the ability of
GRK2 to enhance Smo-mediated, Gli-dependent signaling.
These data indicate that active Smo is required for the ob-
served Smo/GRK2 synergy.
Given that exogenous Smo can synergize with GRK2 to
activate Gli-dependent signaling, we next examined if endog-
enous Smo might also synergize with GRK2. We reasoned that
activation of endogenous Smo, with the Smo agonist SAG,
should mimic exogenous overexpression of Smo. Addition of
SAG to C3H10T1/2 cells in the presence of 10% serum was
sufficient to activate the transfected Gli-responsive promoter
approximately 3.5-fold because of the activation of endoge-
nous Smo (Fig. 2), (5). Treatment of cells transfected with
exogenous Smo or -arrestin 2 with SAG showed an additive
induction over the induction caused by transfection alone. As
expected, transfection of GRK2 into C3H10T1/2 cells that
were subsequently treated with SAG caused a large synergistic
induction (15-fold) of the reporter relative to cells trans-
fected with GRK2 and treated with the vehicle (DMSO) or
cells transfected with an empty expression vector and treated
with SAG (Vector lane, black bar). Together, these results
suggest that GRK2 can synergize with endogenous Smo to
facilitate Gli-dependent signaling.
Signaling through the Smo agonist SAG is GRK2 depen-
dent. As we have observed that Smo-dependent signaling
through Gli can be enhanced by the activity of GRK2, we next
examined the physiological role of endogenous GRK2 in ago-
nist-induced Smo signaling. C3H10T1/2 cells cultured in low-
serum medium respond to the addition of Shh or SAG by
activating Smo and inducing Gli transcriptional activity (5).
These cells were therefore transfected with the Gli-dependent
reporter and a pSilencer vector expressing either a control
shRNA or one of three different shRNAs designed to reduce
the expression of GRK2. Figure 3A shows that SAG-treated
cells that were transfected with the control shRNA induced
Gli-dependent transcription by greater than ninefold over
vehicle-treated cells. However, cells transfected with GRK2
shRNA 1, 2, or 3 were all significantly impaired in the ability to
induce the Gli-dependent reporter upon SAG addition, reveal-
ing the importance of endogenous GRK2 in SAG-induced
signaling. Cells expressing these shRNAs were sorted by flow
cytometry and used for Western blot analysis (Fig. 3B). Figure
3B shows that all of the hairpin RNAs used were capable of
significantly inhibiting the expression of endogenous GRK2.
Thus, the ability of SAG to induce Smo-dependent activation
of Gli depends on the activity of GRK2.
To verify that the effects of the GRK2 shRNAs are in fact
specific, we created an amino acid conservation mutant form
of bovine GRK2 that renders it insensitive to GRK2 2
shRNA. This mutant form, GRK2 2*, was transfected with
GRK2 2 shRNA to rescue SAG-induced signaling. Figure
3C shows that while transfection of multiple plasmids into
these cells reduces the control induction of the reporter by
SAG, inhibition of signaling by the shRNA is still observed.
Addition of the amino acid conservation mutant GRK2 2*
to cells expressing the GRK2 2 shRNA is sufficient to return
FIG. 2. SAG and GRK2 synergy. C3H10T1/2 cells were transfected
with the indicated expression plasmids. After 24 h, cells were split in
half and treated with either the vehicle or SAG for 48 h. Cells were
harvested and assayed for luciferase and gal activities. Luciferase
values were normalized for transfection efficiency with the gal values
of the sample containing the reporter alone. Fold activation refers to
the increase in luciferase activity relative to that of the vehicle-treated
sample containing the reporter alone. The data shown are the results
of at least three independent experiments performed in duplicate.
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SAG-induced signaling to control levels. The GRK2 West-
ern blot assay in Fig. 3D reveals that in fact the GRK2 2*
cDNA is expressed at high levels even in the presence of the
GRK2 2 shRNA. Indeed, the level of GRK2 expression from
the CMV promoter is such that even wild-type GRK2 can
rescue SAG-mediated signaling (data not shown). This is
likely because the overexpression of GRK2 is high enough
to overwhelm the activity of the hairpin, resulting in suffi-
cient remaining GRK2 to mediate signaling. Together, these
data indicate that endogenous GRK2 is required for ago-
nist-induced Smo-mediated signaling.
GRK2 contributes to the transforming potential of Smo.
Given that GRK2 facilitates signaling through endogenous
Smo, we next wanted to determine if GRK2 plays a similar role
in aberrant signaling through oncogenic Smo mutants. The
Smo M2 mutant SmoW535L, originally identified in human
basal cell carcinoma and subsequently found in human medul-
loblastomas, has been shown to superactivate the Gli reporter
(42, 47). Cells were transfected with either wild-type Smo or
the Smo M2 mutant together with either the control or GRK2
2 shRNA. Figure 4A reveals that the GRK2 2 shRNA inhibits
the signaling from both wild-type and mutant Smo. The ex-
pression levels of the Smo and Smo M2 plasmids were com-
pared by expressing the plasmids in HEK 293 cells, which do
not express endogenous Smo. Figure 4B shows that Smo and
Smo M2 are expressed relatively equally. These data thus sug-
FIG. 3. Gli activation through SAG is GRK2 dependent. (A) C3H10T1/2 cells were transfected with the indicated shRNA and the Gli reporter
vector. After 24 h, the cells were split in half and treated with either SAG or the vehicle for 48 h. Cells were then assayed for luciferase activity.
Fold activation by SAG refers to the induction of luciferase activity in SAG-treated cells relative to that of vehicle-treated cells. (B) Cells were
treated as for panel A and sorted by flow cytometry with a cotransfected GFP vector. Extracts from equal numbers of cells were immunoblotted
with GRK2 and actin antibodies. (C) Cells were treated as for panel A with the additional transfection of pCDNA3 or an shRNA-resistant GRK2
2* expression vector. (D) Immunoblotting was performed as for panel B.
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gest that GRK2 plays a role in both wild-type and aberrant
Smo signaling.
Smo M2 is believed to have its oncogenic effects in part
because of an ability to activate the expression of Shh target
genes involved in cell proliferation. Indeed, Smo M2 in this cell
system and others can activate Gli-dependent reporters be-
tween 2.5- and 13-fold more strongly than wild-type Smo (38,
42, 49). Given that the overexpression of Smo together with
GRK2 similarly induces a Gli-dependent reporter better
than wild-type Smo alone, we examined if Smo/GRK2 could
cooperate with Ras 61L to allow the growth of foci in
C3H10T1/2 cells, as has been shown for Smo M2 and E1A in
REF52 cells (47).
Parental C3H10T1/2 cells or cells stably expressing Smo
alone, GRK2 alone, GRK2 K220R alone, Smo together with
GRK2, or Smo together with GKR2 K220R were all trans-
fected with H-Ras 61L. As a control, one set of plates was also
transfected with gal to verify that all cell lines were trans-
fected equally with Ras. Foci were counted after 21 days of
growth. Under these conditions, few foci grew in plates with
the parental cells, Smo alone, GRK2 K220R alone, or Smo
together with GRK2 K220R. Interestingly, several foci repeat-
FIG. 4. GRK2 contributes to oncogenic Smo M2 signaling and cooperates with Smo and Ras to transform C3H10T1/2 cells. (A) C3H10T1/2
cells were transfected with the Gli luciferase reporter, a gal transfection control, and the indicated cDNA and shRNA plasmids. Fold activation
refers to the induction of luciferase activity by the indicated cDNA relative to that of the control sample with the reporter alone containing the
same shRNA. The data shown are the results of three independent experiments. (B) HEK 293 cells were transfected with the indicated expression
plasmids. Cell extracts were normalized for transfection efficiency. Immunoblotting was performed with human Smo antibody. (C) Focus formation
assays. C3H10T1/2 cells stably expressing the indicated proteins were transfected with Ras and stained for foci with crystal violet after 21 days.
Representative fields are shown. At the bottom is a quantification of the number of foci per 60-mm plate (three independent experiments in
duplicate).
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edly formed in cells expressing GRK2 alone. However, the
most significant number of densely packed foci formed in
the plates containing cells expressing Smo and GRK2 to-
gether (Fig. 4C), indicating that Smo and GRK2 together
can cooperate with Ras to produce a transformed phenotype
in C3H10T1/2 cells.
GRK2 facilitates the interaction between active Smo and
-arrestin 2. As GRK2 activity seems to be required for SAG-
induced signaling, we hypothesized that perhaps GRK2 fa-
cilitates the recruitment of a signaling protein to Smo. One
protein known to associate with the C terminus of GRK-phos-
phorylated 7TMRs is -arrestin. Indeed, -arrestin has re-
cently been shown to regulate zebra fish development through
the Shh pathway and to mediate activation-dependent inter-
nalization of Smo in HEK cells (6, 46). To examine if Smo can
recruit -arrestin 2 to the membrane in signaling-competent
cells, we chose to examine -arrestin 2 recruitment in Shh-
LIGHT cells (42), which are more transfectable and less
autofluorescent than C3H10T1/2 cells. Shh-LIGHT cells were
first transfected with a GFP-tagged version of the -arrestin 2
protein with or without Smo. Figure 5A reveals that while
-arrestin 2–GFP expression is uniformly cytoplasmic when
transfected alone, in the presence of cotransfected Smo, it is
localized to the plasma membrane in a punctate pattern.
This pattern of -arrestin 2 localization is reminiscent of
patterns seen when -arrestin is recruited to ligand-stimulated
7TMRs (3). As transfection of Shh-LIGHT cells with Smo
induces pathway stimulation, (42), it is likely that Smo requires
activation in order to recruit -arrestin 2 to the membrane. To
further examine if the recruitment of -arrestin 2 to the mem-
brane is dependent on Smo activity, we transfected -arrestin
2–GFP and Smo together with the Smo inhibitor Ptc. As pre-
viously observed in HEK cells, in the presence of Ptc, -arres-
tin 2 is no longer recruited to the membrane but is again
diffusely cytoplasmic (Fig. 5A) (6). Finally, when the inhibition
of Smo by Ptc is relieved by cotransfection of the N terminus
of the Shh protein, -arrestin 2 is again recruited to the mem-
brane in a punctate pattern, albeit less robustly than with Smo
FIG. 5. Interaction between -arrestin 2 and Smo. (A) Confocal images of Shh-LIGHT cells expressing -arrestin 2–GFP and different Shh pathway
components. The insets are magnifications of the boxed area of the membrane. (B) Quantification of experiments as for panel A with HEK cells with
or without exogenous expression of GRK2. Percentage of cells with -arrestin 2 translocation refers to the percentage of GFP-positive cells that show
punctate -arrestin 2–GFP localization at the plasma membrane. (C) Effect of GRK2 on Smo and -arrestin 2 association. HEK cells were transfected
with the indicated expression plasmids, and extracts were immunoprecipitated (IP) with Flag affinity gel. Immunoprecipitates and total lysates were
immunoblotted (IB) with Myc and Flag antibodies. (D) Effect of cyclopamine on Smo and -arrestin 2 association. Experiments were performed as for
panel C, by treating HEK cells with either the vehicle or cyclopamine for 24 h.
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alone. It therefore seems that this recruitment of -arrestin 2
to the membrane correlates with Smo activation (6).
In canonical 7TMR biology, the activation of a 7TMR via an
agonist results in the phosphorylation of that 7TMR by a GRK.
This phosphorylation event promotes -arrestin 2 recruitment.
To examine if GRK2 can facilitate the observed -arrestin
recruitment to Smo at the membrane, HEK 293 cells and HEK
293 cells stably expressing GRK2 were transfected with GFP–
-arrestin and Smo. Figure 5B shows that while approximately
50% of all Smo-transfected, GFP-positive cells without exog-
enous GRK2 show -arrestin translocation, almost 95% of all
Smo-transfected, GFP-positive cells show -arrestin transloca-
tion when GRK2 is stably expressed. This suggests that GRK2
can enhance the recruitment of -arrestin to Smo at the mem-
brane. Interestingly, while coexpression of Smo and Ptc inhib-
its the translocation of -arrestin, this inhibition of transloca-
tion is less pronounced in the presence of exogenous GRK2.
Given that -arrestin 2 is recruited to the membrane in the
presence of Smo, we next examined if Smo and -arrestin 2
could interact directly and if this interaction could be facili-
tated by GRK2. HEK cells were transiently transfected with
Flag–-arrestin 2, Myc-Smo, or Flag–-arrestin 2 and Myc-
Smo together with or without GRK2. Cells were lysed and
immunoprecipitated with a Flag affinity gel matrix to precipi-
tate Flag–-arrestin 2. As shown in Fig. 5C, Myc-Smo can be
specifically immunoprecipitated with Flag antibody only when
it is coexpressed with Flag–-arrestin 2. Moreover, the coex-
pression of GRK2 enhances the association of Myc-Smo with
Flag–-arrestin 2 by 2.6-fold  0.3-fold (n  3), again suggest-
ing that GRK2 facilitates the association between Smo and
-arrestin 2.
Figure 5A reveals a correlation between the recruitment of
-arrestin 2 to Smo at the membrane and the activity of the
Smo signaling pathway. The Smo antagonist cyclopamine is
known to inhibit Smo signaling. Indeed, Fig. 2A confirms that
cyclopamine abolishes signaling through Smo in our experi-
ments. We therefore tested whether inhibition of Smo activity
by cyclopamine reduces the association between -arrestin 2
and Smo. HEK cells were transfected with Myc-Smo, Flag–-
arrestin 2, or Myc-Smo and Flag–-arrestin 2 together. The
cells were then split into two plates, and one plate was treated
with the vehicle (DMSO) and the other was treated with 5 M
cyclopamine. The immunoprecipitation experiments in Fig. 5D
show that cyclopamine does, in fact, reduce the association
between Smo and -arrestin 2 by more than twofold, as re-
ported previously (6). Taken together, in accordance with pre-
viously published data, these data suggest that active Smo
associates with -arrestin 2. Furthermore, we find that at least
one function of GRK2 in this pathway is to facilitate the in-
teraction between Smo and -arrestin 2.
GRK2 synergy with Smo is dependent on -arrestin 2. Re-
cent data indicating that -arrestin 2 is necessary for Shh
pathway function in zebra fish development suggests that
GRK2 might mediate the observed synergistic effects on
Smo signaling by promoting the recruitment of -arrestin 2
to further transmit the signal (46). The overexpression of
-arrestin 2 in our signaling system has no further effect on
the Gli reporter (Fig. 1A), indicating that perhaps -arrestin
2 is not limiting in C3H10T1/2 cells. We therefore used an
RNA interference approach to reduce levels of cellular
-arrestin 2 to assess its importance in the observed syner-
gistic activation of Gli activity by Smo and GRK2. An
shRNA, arr2-2, was generated to reduce -arrestin 2 ex-
pression. C3H10T1/2 cells were transfected with Smo and
GRK to induce Gli-dependent signaling as measured by
the cotransfected Gli reporter. Figure 6A shows that, in the
presence of the control shRNA, Smo/GRK2 can induce the
Gli reporter approximately sevenfold relative to cells trans-
fected with the control shRNA and the reporter alone. This
induction of the Gli reporter through Smo/GRK2 is signif-
icantly inhibited (P 	 0.001) when the -arrestin 2 shRNA
is coexpressed, suggesting that -arrestin 2 contributes to
the observed synergy between Smo and GRK2. The repre-
sentative Western blot assay in Fig. 6B shows that the
arr2-2 shRNA reduces the expression of -arrestin 2 in
C3H10T1/2 cells by approximately 50%. Thus, there is a
correlation between the extent of reduction in signaling and
the reduction in -arrestin 2 expression levels. Indeed, other
arr2 shRNAs and small interfering RNAs that reduce the
expression of endogenous -arrestin 2 by less than 40% also
modestly but significantly inhibit the ability of Smo/GRK2 to
activate the Gli reporter (data not shown).
FIG. 6. Smo/GRK2 synergy is -arrestin 2 dependent. (A) C3H10T1/
2 cells were transfected with the indicated shRNAs and the Gli reporter
with either Smo and GRK2 expression plasmids or a pCDNA3 control
plasmid. Fold activation refers to the induction of luciferase activity in
samples transfected with Smo and GRK2 relative to that of samples with
pCDNA3. Luciferase values were adjusted for transfection efficiency with
a cotransfected gal vector. The data shown are the results of three
independent experiments performed in triplicate. Significance (**, P 	
0.001) was measured with the Student t test (Microsoft Excel). (B) Cells
were transfected as for panel A and sorted by flow cytometry for a
cotransfected GFP vector. Extracts from equal numbers of cells were
immunoblotted with -arrestin (A1CT) and actin antibodies.
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DISCUSSION
Smo is a 7TM protein with structural similarities to classical
7TMR proteins. The paucity of data linking Smo to G-protein-
dependent signaling raises the possibility that Smo may signal
through less-well-appreciated pathways of 7TMRs that utilize
GRKs and -arrestins as positive signaling molecules (26, 27).
In support of this possibility, recent work has shown that
GRK2 is the predominant kinase involved in the phosphory-
lation of active Smo in a mammalian cell line (HEK 293) and
that -arrestin 2 is necessary for Shh-mediated signaling during
zebra fish development (6, 46). Here we provide evidence
supporting a positive role for GRK2/-arrestin 2 in Smo-me-
diated signaling in a cellular system. Furthermore, unpublished
work from this laboratory also demonstrates that GRK2 plays
a positive role in Smo-dependent zebra fish development
(G. B. Fralish, unpublished data). Taken together, these find-
ings suggest that GRK2 functions in this pathway as a mediator
of signaling, at least in part, by facilitating the recruitment of
-arrestin 2 to Smo.
Mice with a targeted deletion of GRK2 were generated 10
years ago (18). These mice die at embryonic day 15.5 with
hypoplasia of the ventricular myocardium. While at the time
no connections were made that GRK2 may be important for
Shh-mediated signaling, recent literature suggests that Shh
signaling plays an important role in cardiomyogenesis and
heart situs, offering a possible explanation for the observed
phenotype of GRK2 knockout mice (14, 28). Interestingly,
mice with a targeted deletion of -arrestin 2 show no devel-
opmental defects that might be expected of mice with an Shh
pathway mutation. However, -arrestin 1 may be able to com-
pensate for the loss of -arrestin 2 in these mice. Mice with
disruptions of both -arrestin 1 and -arrestin 2 are embryonic
lethal, but the developmental defects of these mice have yet to
be examined (F.-T. Lin and R. J. Lefkowitz, unpublished ob-
servations). Thus, the phenotype of at least the GRK2 knock-
out mice further suggests a possible role for GRK2 in Shh
signaling.
We find that the kinase domain of GRK2 is essential for the
observed synergy between GRK2 and Smo. What, then, might
GRK2 do to promote Smo signaling? One possibility is that
GRK2 phosphorylates other components in the Smo signaling
cascade such as Fused, SuFu, or Kif27/Kif7, which in Drosoph-
ila are phosphorylated upon Hh pathway activation (for a
review, see reference 48). This phosphorylation may then
activate or inhibit the function of these signaling proteins.
Interestingly, GRK2 has been shown to phosphorylate beta-
tubulin, a component of microtubules (37a). As microtubules
are part of the large cytoplasmic complex containing Fused,
Costal2, and Ci in Drosophila, perhaps GRK2 facilitates the
disruption of this complex, promoting entry of Ci/Gli into the
nucleus to activate transcription. Alternatively, as microtubules
are the main component of cilia, a cellular organelle recently
touted as the location of Smo signaling function, it is also
possible that GRK2 may aid in ciliary function (9, 15).
A second possibility is that GRK2 mediates the observed
positive effects by facilitating the recruitment of other cellular
factors to Smo. The most obvious such factor is the -arrestin
protein. Several recent papers have shown that PKA and ca-
sein kinase I (CKI) can directly phosphorylate Drosophila Smo
(20, 48). It has been proposed that this phosphorylation pro-
motes Smo signaling by inducing a conformational change that
allows the binding of Costal 2 or other cellular factors that
facilitate signaling (48). As these phosphorylation sites are not
conserved between Drosophila and mammals, it is possible
that, in mammalian systems, GRK2 plays the role of PKA and
CKI by directly phosphorylating the C terminus of Smo. This
might, then, similarly induce the conformational changes nec-
essary for the recruitment of other cellular factors, such as
-arrestin, that then mediate signaling.
In classical 7TMR biology, the phosphorylation of a 7TMR
by a GRK facilitates the recruitment of -arrestins to the
receptor. Indeed, -arrestin 2 is similarly recruited to active
Smo and this recruitment is enhanced, in both -arrestin 2
translocation assays and in coimmunoprecipitation assays, by
GRK2. We also find that reducing -arrestin 2 expression
through shRNAs reduces the synergistic activation of the Gli-
dependent reporter by GRK2 and Smo. Perhaps one reason
for a less-than-complete inhibition of reporter activation by the
-arrestin 2 hairpin is the remaining cellular -arrestin 2 pro-
tein levels. As -arrestin 2 is likely not limiting in C3H10T1/2
cells, a reduction of protein expression by 50%, such as that
achieved with one shRNA, may only be sufficient to reduce
signaling but not abolish it. Similar findings were obtained
when -arrestin 2 expression was reduced by small interfering
RNAs. Unfortunately, attempts to rescue the Smo/GRK2 syn-
ergy with an amino acid conservation mutant form of -arres-
tin 2 have been unsuccessful. However, this may well be due to
a “squelching effect,” where overexpressed -arrestin 2, which
likely acts as a scaffold rather than as an enzyme, sequesters
essential signaling components in unproductive complexes. In
addition, these shRNAs have no effect on pathway activation
mediated by SAG. This may reflect the difference between the
amounts of -arrestin 2 required for recruitment to endoge-
nous Smo versus the amounts of -arrestin2 required under
conditions in which Smo is overexpressed.
Although there are many possibilities for how GRK2 may
act to induce Smo signaling, we favor the hypothesis that
GRK2 facilitates the recruitment of other cellular factors to
Smo, as has been hypothesized for Drosophila Smo phosphor-
ylation by PKA and CKI (48). We show here that GRK2
facilitates the recruitment of -arrestin 2 to active Smo, likely
through direct phosphorylation of Smo. There are several pos-
sible ways in which -arrestin might then transmit the signal.
First, the recruitment of -arrestin 2 to Smo has been shown
previously to promote Smo internalization (6). This internal-
ization may be necessary for Smo trafficking to other cellular
locales or environments that favor signaling. For example, it
has recently been appreciated that the primary cilium functions
as a specialized organelle for Smo signal transduction (9, 15,
32). Indeed, Smo mutants that inhibit ciliary localization also
inhibit Smo signaling. It has also been observed that -ar-
restins are concentrated in the cilia, consistent with the possi-
bility of a role for -arrestin 2 in this process (9, 10). Another
way in which -arrestin may function to transmit the signal is
that upon recruitment to Smo, -arrestin 2 may scaffold other
cellular signaling components, resulting in the activation of
signaling cascades (4, 27, 41). Indeed, several other 7TM pro-
teins mediate the activation of mitogen-activated protein ki-
nases through -arrestin 2-dependent “signalosomes.” More-
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over, recent studies have found that Shh and Smo agonists
activate ERK (29, 37). While the exact mechanisms by which
-arrestin/GRK2 functions in the Smo pathway remain to be
established, these findings suggest that GRK2 inhibitors may
offer a novel avenue for investigation of therapeutics for can-
cers caused by Shh pathway deregulation.
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